Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology and Market Size Forecast - 2020; New Report Launched

Lewes, DE -- (SBWIRE) -- 03/03/2016 -- Idiopathic pulmonary fibrosis (IPF) - Market Insights, Epidemiology and Market Size Forecast-2020 Reports provides an overview of the disease and global market size of the Idiopathic pulmonary fibrosis (IPF) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Idiopathic pulmonary fibrosis (IPF) from 2010-2020.Hemophilia is a bleeding disorder that slows the blood clotting process. People with this condition experience prolonged bleeding or oozing following an injury, surgery, or having a tooth pulled. The major types of this condition are hemophilia A (also known as classic hemophilia or factor VIII deficiency) and hemophilia B (also known as Christmas disease or factor IX deficiency). Although the two types have very similar signs and symptoms, they are caused by mutations in different genes. Gene therapy might eventually help people with hemophilia begin producing their own clotting factor, alleviating the need for or reducing the number of weekly infusions.